Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Apr 8;16(4):e0249960. doi: 10.1371/journal.pone.0249960

Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis

Agajie Likie Bogale 1,*, Tilahun Teklehaymanot 2, Jemal Haidar Ali 3, Getnet Mitike Kassie 4
Editor: Saeed Ahmed5
PMCID: PMC8031808  PMID: 33831128

Abstract

Background

To establish successful strategies and increasing the utilization of preventive services, there is a need to explore the extent to which the general female population is aware and use the service for cervical cancer-screening among women infected with HIV in Africa. Available evidences in this regard are controversial and non-conclusive on this potential issue and therefore, we estimated the pooled effect of the proportion of knowledge, attitude and practice of HIV infected African women towards cervical cancer screening to generate evidence for improved prevention strategies.

Methods

We applied a systematic review and meta-analysis of studies conducted in Africa and reported the proportion of knowledge, attitude and practice towards cervical cancer screening. We searched electronic databases: PubMed/Medline, SCOPUS, ScienceDirect, Web of science, Cumulative Index of Nursing and allied Health Sciences (CINAHL) and Google scholar databases to retrieve papers published in English language till August 2020. We used random-effects model to estimate the pooled effect, and funnel plot to assess publication bias. The registration number of this review study protocol is CRD42020210879.

Results

In this review, we included eight published papers comprising 2,186 participants. The estimated pooled proportion of knowledge of the participants was 43.0% (95%CI:23.0–64.0) while the pooled estimates of attitudes and practices were 38.0% (95%CI: 1.0–77.0) and 41.0% (95%CI: 4.0–77.0), respectively. The proportion of the outcome variables were extremely heterogeneous across the studies with I2> 98%).

Conclusion

The pooled estimates of knowledge, attitude and practice were lower than other middle income countries calls for further activities to enhance the uptake of the services and establish successful strategies.

Introduction

Cancer of the cervix uteri is the 3rd most common cancer among women worldwide, with an estimated 569,847 new cases and 311,365 deaths with a greater number of cases (119,284) and deaths (81,687) in Africa, according to the(GLOBOCAN 2018, an online database providing estimates of incidence and mortality) [1]. This death report is even higher than worldwide report in 2012 indicating that 266,000 women died of cervical cancer–equivalent of one woman dying every 2 minutes with about 90% of these deaths occurring in low- and middle-income countries [2].

Cancer of the cervix is the second most commonly diagnosed cancer after breast cancer and the third leading cause of cancer death after breast and lung cancers in developing countries [3]. It also ranks second next to breast cancer in Ethiopia [4].

One of the strategies to minimize the burden of the disease is to establish successful strategies and increasing the utilization of preventive measures ranging from community education, social mobilization, vaccination, screening, and treatment to palliative care [5].

Most importantly, increasing the knowledge, attitude and practice (KAP) of cervical cancer screening and prevention among females is a part of a comprehensive approach to cervical cancer prevention and control strategy. This might play a pivotal role in the controlling strategy on the issue. Health workers considered to take a lead in this regard are found to have less knowledge about cervical cancer as a disease and relatively fair knowledge on Pap smear testing [6]. Among women who had been attending a tertiary hospital, the majority had a positive attitude while about a third had good knowledge and very few (2.7%) had good practice [7]. When looked at the patients suffered gynecological cancer, more than half of them knew that their disease was malignant [8]. In addition, different evidence about knowledge, attitude and practice were generated at different corners of Asian countries [912] that seek for pooling of the findings for decision making.

In Africa, the findings indicate that the cervical cancer screening approach is in its infancy stage. For instance, in rural Uganda, only 4.8% of women had ever been screened for cervical cancer [13] and around ten percent in Burkina-Faso [14]. In Ethiopia, including University female students, their KAP is fair towards cervical cancer and scored less than fifty percent [1518].

On the basis of the comprehensive literature search made, variability on the KAP score prevails in various African countries and assumed to have high prevalence of the problem and with unavailability of information among the female population living with HIV who are the most vulnerable population.

Therefore, this review aims to estimate the pooled effect of the proportion of KAP of HIV infected African women towards cervical cancer screening to generate evidence for improved prevention strategies.

Materials and methods

Search strategy and screening of papers

We conducted a systematic review and meta-analysis of published articles to estimate the pooled effect or the proportion of knowledge, attitude and practice towards cervical cancer screening in Africa. We systematically searched the papers published in the following electronic databases; PubMed/Medline, SCOPUS, ScienceDirect, Web of science, Cumulative Index of Nursing and allied Health Sciences (CINAHL) and Google scholar. The review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standard [19] as displayed in S1 Table. We used a search strategy by combining the following key terms: knowledge, attitude, practice, cervical cancer, uterine cervical neoplasms, cervical cancer screening, human immunodeficiency virus or HIV, and Africa. We used Truncation(*) to manage spelling variation during search: infect* or positive, wom*n or female* or girl*. We used both free text and Medical subject heading [MeSH]terms during electronic database search.

PubMed database search strategy was: (((((((knowledge) AND ((((cervical cancer) OR (Uterine Cervical Neoplasms)) OR (cervical cancer screening[tiab])) OR (cervical cancer screening[MeSH Terms]))) AND ((Attitude) AND ((((cervical cancer) OR (Uterine Cervical Neoplasms)) OR (cervical cancer screening[tiab])) OR (cervical cancer screening[MeSH Terms])))) AND ((practice) AND ((((cervical cancer) OR (Uterine Cervical Neoplasms)) OR (cervical cancer screening[tiab])) OR (cervical cancer screening[MeSH Terms])))) AND ((human immunodeficiency virus) OR (HIV))) AND ((infect*) OR (positive))) AND ((women) OR (female*))) AND (Africa) AND ((y_10[Filter]) AND (female[Filter]) AND (english[Filter]))

The search was repeated to identify the consistency of search terms and result. Two authors (AL and JH) independently reviewed the titles, abstracts and full articles of retrieved studies.

Study inclusion and exclusion criteria

In this review, we included a cross sectional studies conducted in Africa that reported Knowledge, attitude and practice towards cervical cancer screening. The inclusion was restricted to papers published from 2010 to August 2020 in the English language within a ten year period though data were available from 2014 to 2019. We excluded those studies that did not clearly state the outcome measures, study population different from HIV infected women or females, duplication citations, and review articles [Fig 1].

Fig 1. Flow diagram of studies reviewed, screened and included.

Fig 1

Study quality assessment

We assessed the quality of included studies by using the 14 items Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies—NHLBI, NIH [20]. This assessment tool mainly focused on research question, study population, eligibility criteria (inclusion and exclusion criteria of study participants), sample size justification, exposure measures and assessment, sufficient time frame to see an effect, outcome measures and blinding of outcome assessors, follow up rate, and statistical analysis. The quality assessment was rated as good, fair and poor based on quality assessment tool criteria. The maximum score indicating high quality was 14 and the lowest possible score was zero. The rating values of the included studies in terms of their quality were based on their design. Cross-sectional types do not consider the items which fit for cohort and taken as not-applicable (NA) and thus, the rating values were not taken from the possible maximum score (i.e. 14). In this review, all scores are written in percentage beside the results individual components of the quality assessment [S2 Table].

Data extraction

We extracted data from eligible abstract and/or full text of the articles by considering the outcome variables and the characteristics of participants such as age range, mean or median age, sex, HIV sero-status. In addition, we extracted the study characteristics such as first author, year of publication, study setting, study location or country, study design, sample size, knowledge score, attitude and practice [Table 1].

Table 1. Characteristics of included studies to estimate the pooled effect of knowledge, attitude and practice of HIV-infected women towards cervical cancer in Africa.

First Author Year Study setting Study location Study design Sample size Knowledge Attitude Practice Age range/mean age in years
Solomon et al [24] 2019 Health facility Ethiopia Cross-sectional 475 119 36
Shiferaw et al [25] 2018 Health facility Ethiopia Cross-sectional 581 136 35
Mitchell et al [26] 2017 Health facility Uganda Cross-sectional 87 1 30–69
Stuart et al [27] 2019 Health facility Ghana Qual-Quantof parent cohort 60 48 > = 18
Adibe & Aluh [28] 2017 Health facility Nigeria Cross-sectional 447 45 194 > = 9
Belglaiaa et al [29] 2018 Health facility Morocco Cross-sectional 115 24 15 34.9
Rosser et al [30] 2015 Health facility Kenya Cross-sectional 106 69 74 89 34.9
Maree & Moitse [31] 2014 Health facility South Africa Cross-sectional 315 198 38.9

The proportions of knowledge, attitude and practice is written in number to make the data which fit for meta-analysis using metaprop.

Statistical analysis

We estimated the pooled proportion of knowledge, attitude and practice of HIV positive women on cervical cancer screening with its 95% Confidence Interval (CI) using random effects meta-analysis model assuming the true effect size varies between studies [21]. The proportion of knowledge, attitude and practice reported in each included study is multiplied by its sample size to express the score in number, and data presented in forest plot.

We assessed heterogeneity in the proportions of different studies using heterogeneity Chi-square (x2) based Q test with significant level of p-value < 0.1 and I2. The I2value 25% indicates low heterogeneity while 50% moderate and 75% high [22]. We assessed the potential publication bias using funnel plot. If the 95% of the point estimates of the included studies lie within the funnel plot defined by straight lines, then that indicates the absence of heterogeneity [23]. We used moment based meta-regression to assess the potential source of heterogeneity. Data analysis was conducted using STATA version 14.

Ethical approval and consent to participate

Since the review made was based on previously published articles, there was no need for ethical clearance. Nevertheless, the protocol of the study was pre-registered on PROSPERO (International prospective register of systematic reviews) University of York, Centre for Reviews and Dissemination with registration number CRD42020210879.

Operational definition of KAP in this protocol

Knowledge (K). Refers to the awareness of HIV positive women towards cervical cancer screening in Africa. Different pocket studies are filtered and eligible articles are included in the analysis to estimate the pooled knowledge.

Attitude (A). Refers to the way of thinking or feeling of HIV positive women on cervical cancer screening.

Practice (P). Refers to the habit of women to be screened for cervical cancer.

Results

Study characteristics

We included eight studies [Fig 1], from Ethiopia [24, 25], Uganda [26], Ghana [27], Nigeria [28], Morocco [29], Kenya [30], and South Africa [31] which are health facility based [Table 1]. Almost all the included studies were cross-sectional types published from 2014 to 2019 though the extraction of data was done for the past ten years till August 2020. The maximum sample size reported was 581 [25] while the minimum was 60 [27]. The age of respondents ranged from 9 to 69 years [Table 1].

Pooled estimates of knowledge of HIV positive women towards cervical cancer screening in Africa

We pooled data from 2,186 HIV positive women to estimate the pooled proportion of knowledge on cervical cancer screening using meta-analysis. The overall pooled proportion of knowledge was 43.0% [Fig 2] with high heterogeneity across the studies(chi2 = 493.23 (d.f. = 5), p = 0.001, and I2 = 98.99%).

Fig 2. Forest plot to estimates the proportion of knowledge among HIV infected women towards cervical cancer screening in Africa with 95% CI (the estimate weighted based on random effects model): ES-Effect size equivalent to the proportion, CI-Confidence interval.

Fig 2

In the plot, the diamond shows the pooled result and the boxes show the effect estimates from the single studies. The purple dotted vertical line indicates pooled estimate. The purple solid vertical line indicates the reference line at zero indicating no effect. The horizontal line through the boxes illustrate the length of the confidence interval and the boxes show the effect estimates from the single studies.

Pooled estimates of the attitude and practice of HIV positive women towards cervical cancer screening in Africa

Meta-analysis using few studies included is not recommended due to less precision. In this review, only three studies included in the analysis to estimate the pooled effect, which was the attitude and practice of HIV positive women towards cervical cancer screening. The pooled estimates of attitude was 38.0% [Fig 3] with high heterogeneity across the studies (chi2 = 437.57 (d.f. = 2), p = 0.001, I^2 (variation in ES attributable to heterogeneity) = 99.54%) while the pooled practice estimate was 41.0% [Fig 4] with high level of heterogeneity (chi2 = 260.80 (d.f. = 2), p = 0.001, I^2 (variation in ES attributable to heterogeneity) = 99.23%).

Fig 3. Forest plot to estimates the proportion of attitude among HIV infected women towards cervical cancer screening in Africa with 95% CI (the estimate weighted based on random effects model): ES-Effect size equivalent to the proportion, CI-Confidence interval.

Fig 3

In the plot, the diamond shows the pooled result and the boxes show the effect estimates from the single studies. The purple dotted vertical line indicates pooled estimate. The purple solid vertical line indicates the reference line at zero indicating no effect. The horizontal line through the boxes illustrate the length of the confidence interval and the boxes show the effect estimates from the single studies.

Fig 4. Forest plot to estimates the proportion of practice among HIV infected women towards cervical cancer screening in Africa with 95% CI (the estimate weighted based on random effects model): ES-Effect size equivalent to the proportion, CI-Confidence interval.

Fig 4

In the plot, the diamond shows the pooled result and the boxes show the effect estimates from the single studies. The purple dotted vertical line indicates pooled estimate. The purple solid vertical line indicates the reference line at zero indicating no effect. The horizontal line through the boxes illustrate the length of the confidence interval and the boxes show the effect estimates from the single studies.

Meta-regression analysis

We assessed the effect of sample size and year of the study on heterogeneity between the studies using meta-regression model. However, there was no significant prediction of heterogeneity between the effect size and the assessed variables (i.e., both sample size and year of the study) [Table 2]. Meaning, in the adjusted model, both sample size and year of the study didn’t indicate heterogeneity in the effect size which is equivalent to the pooled proportion (P > 0.05). When we interpret the finding using β-coefficient, one unit increase in the publication year will decrease the outcome variable by the coefficient of 20.14 points and an increase in the sample size will depict a slight increase (0.14 points) in the outcome [Table 2].

Table 2. Meta-regression analysis for year of study and sample size as a reason of heterogeneity on the knowledge estimates of women infected by HIV in Africa.

Variable Adjusted model
ß(95% CI) SE P-value
Sample size 0.14(-0.24–0.52) 0.12 0.32
Publication year -20.14(-61.7–21.4) 13.1 0.22

SE-Standard error, ß-regression coefficient, 95% CI Confidence interval

Publication bias

The funnel plot (widely used to examine bias in the result of a meta-analysis) for pooled estimates of knowledge, attitude and practice towards cervical cancer screening indicated that there was publication bias. The included studies are scattered out of pseudo 95% confidence limit and the observed bias might be due to small study effect [Fig 5A–5C]. Fig 5A, indicates funnel plot of the 6 estimates of knowledge (k) towards cervical cancer screening available for meta-analysis (SE-Standard error, ES-Effect size: proportion), (b) Funnel plot of the 3 estimates of attitude (A) towards cervical cancer screening available for meta-analysis (SE-Standard error, ES-Effect size: proportion), (c) Funnel plot of the 3 estimates of practice towards cervical cancer screening available for meta-analysis (SE-Standard error, ES-Effect size: proportion).

Fig 5. Publication bias assessment: a) Funnel plot of the 6 estimates of knowledge (k) towards cervical cancer screening available for meta-analysis (SE-Standard error, ES-Effect size: proportion), b) Funnel plot of the 3 estimates of attitude (A) towards cervical cancer screening available for meta-analysis (SE-Standard error, ES-Effect size: proportion), c) Funnel plot of the 3 estimates of practice towards cervical cancer screening available for meta-analysis (SE-Standard error, ES-Effect size: proportion).

Fig 5

In this plot, the blue broken line indicates Pseudo 95% CI, the solid red line indicates pooled estimate of the proportion of knowledge, attitude and practice, and the scattered circle dots indicates included studies in the meta-analysis. The scale on the X-axis indicates Effect size estimate or proportion and the Y-axis indicates the precision estimate using standard Error.

In this plot, the blue broken line indicates Pseudo 95% CI, the solid red line indicates pooled estimate of the proportion of knowledge, attitude and practice, and the scattered circle dots indicates included studies in the meta-analysis. The scale on the X-axis indicates Effect size estimate or proportion and the Y-axis indicates the precision estimate using standard Error.

Discussion

In this review, the pooled estimate of knowledge, attitude and practice of HIV infected women towards cervical cancer screening in Africa was 43.0%, 38.0% and 41.0%, respectively. The highest heterogeneity and publication bias were observed in meta-analysis using forest plot and funnel plot, respectively. The Meta-regression model was applied to identify the reason for heterogeneity using sample size and publication years. However, the variation did not show a significant association on the effect size equivalent to the proportion or the outcome variables.

The knowledge estimate of our finding was concordant with previously reported review findings in Ethiopia among women of reproductive age group (40.37%) [32] while the attitude and practice findings varied and were 58.87% and 14.02%, respectively [32]. Such variations are likely due to the fact that the study population and settings studied were different from our current review focused on HIV positive women in Africa.

Similarly, Kasraeian et al also in their review made in low and middle-income countries indicated that HIV positive women had less knowledge about cervical cancer and were less likely to undergo screening [33].

The original research articles conducted in different Asian countries, including Pakistan illustrated that participants of the study had inadequate knowledge, attitude and practice towards cervical cancer [34]. In the same breath, Iraqi participants only 30.3% of employed and 40.0% of the students of the female population had positive attitude towards cervical cancer screening [35]. Similarly, a study conducted in India indicated that 30.2% of respondents had good knowledge and almost one fourth (25.9%) had a favorable attitude towards cervical cancer [9] with an inspiring result of 58.9% documented for female health care providers’ knowledge of cervical cancer screening [10]. Another study adds up, only 36.48% of the participants have good knowledge and of these, 83.78% of them had a positive attitude, though the vast majority (97.29%) had no practice [7] revealing a big gap between attitude and practice. The study conducted in the Eastern China also reported slightly over half (51.9%) of rural women to have high knowledge of whom, 96.0%of them expressed positive attitude and 63.7% were screened for cervical cancer [11]. Another study from Nepal also reported 42.9% of women to have knowledge and more than 85.0% to have had a positive attitude towards cervical screening [12]. Whereas the Iranian study showed more than half (58.0%) of patients with cancer knew that their diseases was malignant [8].

When looked at the African continent, very diverse findings were also reported. According to the Tanzania study, only 10.4% of women were knowledgeable about cervical cancer and 7.9% of these were screened [36] which was very low. Similarly, in Nigeria18.1% of them had good knowledge with 67.8% of them to have a positive attitude to cervical cancer screening [37]. In Uganda and Burkina-Faso, the two studies reported that only 4.8% and 11.1% of women had been screened for cervical cancer, respectively [13, 14]. The various studies done in Ethiopia also showed different results [1518]. The study done among University female students in Debre-Berhan, North Ethiopia reported 35.6%, while the study in Wolaita, southern Ethiopia among women of reproductive age reported 43.1% to have good knowledge towards cervical cancer showing better results [15, 16]. Of the 43.1% of the women, studied in Wolaita, 45.5% of them had a positive attitude with 22.9% of them to undergo for screening [16]. On the other hand, the study done in Addis Ababa reported 27.7% of women to have adequate knowledge of cervical cancer and 25.0% of these to undergo for cervical cancer screening [17]. The lowest score for knowledge in Ethiopia was documented for Gonder, northern Ethiopia and it was 19.87% underscoring the need for more advocacy work [18].

Such variable findings of the studies in different countries encouraged us to estimate the pooled effect equivalent to the proportion of the finding which is very crucial for program direction on cervical cancer screening and prevention measure aspects.

Strength and limitations of the study

The strength of this review is that we attempted to include the most vulnerable population, women living with HIV in Africa, and has captured the recent publications within ten years till August 2020 and used more than five biomedical databases. The limitation however, is the inclusion of those papers published and reported only in English language which might have missed other important works done in this regard. The precision of the pooling effect might have been also affected by the fact that only very few studies which reported attitude and practice were included and this might consequently affect the assertion.

Conclusion

The pooled estimates of knowledge, attitude and practice of the current review finding was below half in different African countries. The enhancement of knowledge, attitude and practice of women will augment the comprehensive approach to cervical cancer prevention and control strategy. The current work has shed light-on how much the findings of the studies conducted in different countries on the cervical cancer and its screening were very diverse and difficult for decision making. Thus, it is essential to have the pooled estimates of different findings for decision making. Other than this, the pooled estimates are very crucial for further strengthening the strategies for prevention measure and control of cervical cancer mainly on vulnerable population like women infected by HIV.

Supporting information

S1 Appendix. PROSPERO International prospective register of systematic reviews.

(PDF)

S1 Table. PRISMA assessment checklist.

(DOC)

S2 Table. The results of the individual components of the quality assessment.

(DOCX)

Acknowledgments

The authors acknowledge the contribution of Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Program of Tropical and Infectious Diseases and Ethiopian Public Health Institute (EPHI) for the opportunity to access an internet. The unreserved support rendered by Minilik Demesie from EPHI during the reviewing process of the study protocol was highly appreciable.

Abbreviations

CI

Confidence interval

df

degree of freedom

HIV

Human Immunodeficiency virus

I2

Heterogeneity

KAP

Knowledge, attitude and practice

MeSH

Medical subject heading

tiab

Title and abstract

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.WHO. Cervix uteri, Source: Globocan 2018
  • 2.World Health Organization, “UN Joint Global Programme on Cervical Cancer Prevention and Control,” 2016. [Google Scholar]
  • 3.KGaA M., “Global Burden of Cancer in Women,” Int. J. C, vol. 10, pp. 74–75, 2014. [Google Scholar]
  • 4.“Human Papillomavirus and Related Diseases Report, Ethiopia", June 2019.
  • 5.WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women, 2013
  • 6.Heena H, Durrani S, AlFayyad I, Riaz M, Tabasim R, Parvez G, et al. , “Knowledge, Attitudes, and Practices towards Cervical Cancer and Screening amongst Female Healthcare Professionals: A Cross-Sectional Study,” Journal of Oncology, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Varadheswari T, Dandekar RH, and Sharanya T, “A Study on the Prevalence and KAP Regarding Cervical Cancer Among Women Attending a Tertiary Care Hospital in Perambalur,”International Journal of Preventive Medicine Research 2015; Vol. 1, No. 3: pp. 71–78 [Google Scholar]
  • 8.Eftekhar Z, and Yarandi F, “Knowledge and Concerns about Cancer in Patients with Primary Gynecologic Cancers,” Asian Pacific Journal of Cancer Prevention 2004, Vol 5: pp. 213–216 [PubMed] [Google Scholar]
  • 9.Brogen Singh Akoijam,et al. “Awareness of cervical cancer and its prevention among women of reproductive age group (15–49 years) in Bishenpur District, Manipur: A cross-sectional study.” IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2020; 19(2): pp. 30–37. [Google Scholar]
  • 10.Anantharaman VV, Sudharshini S, Chitra A, “A cross-sectional study on knowledge, attitude, and practice on cervical cancer and screening among female health care providers of Chennai corporation,Journal of Academy of Medical Sciences 2012; 2(4): pp. 124–128 [Google Scholar]
  • 11.Liu T, Li S, Ratcliffe J, and Chen G. “Assessing Knowledge and Attitudes towards Cervical Cancer Screening among Rural Women in Eastern China,”Int. J. Environ. Res. Public Health 2017, 14, 967. 10.3390/ijerph14090967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shrestha J, Saha R, Tripathi N. Knowledge, Attitude and Practice regarding Cervical Cancer Screening Amongst Women visiting Tertiary Centre in Kathmandu, Nepal. Nepal Journal of Medical sciences 2013;2(2):85–90. [Google Scholar]
  • 13.Ndejjo R, Mukama T, Musabyimana A, Musoke D. Uptake of Cervical Cancer Screening and Associated Factors among Women in Rural Uganda: A Cross Sectional Study, PLoS ONE 2016; 11(2): e0149696. 10.1371/journal.pone.0149696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sawadogo B, Gitta SN, Rutebemberwa E, Sawadogo M, and Meda N. Knowledge and beliefs on cervical cancer and practices on cervical cancer screening among women aged 20 to 50 years in Ouagadougou, Burkina Faso, 2012: a cross- sectional study, Pan African Medical Journal 2014; 18:175 10.11604/pamj.2014.18.175.3866 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mruts KB, and Gebremariam TB, “Knowledge and Perception Towards Cervical Cancer among Female Debre Berhan University Students,” Asian Pac J Cancer Prev 2018, 19 (7), 1771–1777 10.22034/APJCP.2018.19.7.1771 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tekle T, Wolka E, Nega B, Kumma WP, and Koyira MM, “Knowledge, Attitude and Practice Towards Cervical Cancer Screening Among Women and Associated Factors in Hospitals of Wolaita Zone,” Cancer Management and Research 2020:12; pp. 993–1005 10.2147/CMAR.S240364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Getachew S, Getachew E, Gizaw M, Ayele W, Addissie A, Kantelhardt EJ. Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia. PLoS ONE 2019;14(5): e0216522. 10.1371/journal.pone.0216522 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mengesha A, Messele A, and Beletew B, “Knowledge and attitude towards cervical cancer among reproductive age group women in Gondar town, North West,”BMC Public Health 2020; 20(209) pp. 1–10 10.1186/s12889-020-8229-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.“PRISMA 2009 Checklist Section / topic PRISMA 2009 Checklist,” pp. 1–2, 2009.
  • 20.“Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies,”2017, pp. 1–4 [Google Scholar]
  • 21.Borenstein M, Hedges LV, Higgins JPT, and Rothstein HR, Introduction to Meta analysis, 2009. [Google Scholar]
  • 22.Higgins JPT, Thompson SG, Deeks JJ, and Altman DG, “Measuring inconsistency in meta-analyses,” 2003, pp. 557–560. 10.1136/bmj.327.7414.557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sterne JAC, and Harbord RM, “Funnel plots in meta-analysis,”2004, no. 2, pp. 127–141 [Google Scholar]
  • 24.Solomon K, Tamire M, and Kaba M, “Predictors of cervical cancer screening practice among HIV positive women attending adult anti-retroviral treatment clinics in Bishoftu town, Ethiopia: the application of a health belief model,” BMC Cancer (2019) 19:989 10.1186/s12885-019-6171-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Shiferaw S, Addissie A, Gizaw M, Hirpa S, W. Ayele W, Getachew S, et al., Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV- positive women attending public health centers in Addis Ababa city, Ethiopia; Cancer Medicine 2018; 7(3):903–912 10.1002/cam4.1334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mitchell SM, Pedersen HN, Stime EE, Sekikubo M, Moses E, Mwesigwa D, et al. , “Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity,” BMC Womens. Health, (2017) 17:4 pp. 1–10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Stuart A, Obiri-yeboah D, Adu-sarkodie Y, Hayfron-benjamin A, Akorsu AD, and Mayaud P, “Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening,” BMC Women’s Health (2019) 19:123; pp. 1–11 10.1186/s12905-019-0818-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Adibe MO, and Aluh DO, “Awareness, Knowledge and Attitudes Towards Cervical Cancer Amongst HIV-Positive Women Receiving Care in a Tertiary Hospital in Nigeria,” J Canc Educ (2018) 33:1189–1194 [DOI] [PubMed] [Google Scholar]
  • 29.Belglaiaa E, Souho T, Badaoui L, et al. Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco. BMJ Open 2018;8:e020343. 10.1136/bmjopen-2017-020343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rosser JI, Njoroge B, and Huchko MJ, “Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya,” J Canc Educ (2015) 30:567–572 10.1007/s13187-014-0787-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Maree J.E. & Moitse K.A., ‘Exploration of knowledge of cervical cancer and cervical cancer screening amongst HIV- positive women’, Curationis 2014; 37(1), Art.#1209, 7 pages. 10.4102/curationis.v37i1.1209 [DOI] [PubMed] [Google Scholar]
  • 32.Alamneh YM, Alamneh AA, and Shiferaw AA. “Knowledge, Attitude, and Practice of Cervical Cancer Screening and Associated Factors Among Reproductive Aged Women in Ethiopia: A Meta- Analysis and Systematic Review,” pp. 1–19. [Google Scholar]
  • 33.Kasraeian M, Hessamia K, Vafaei H, Asadi N, Foroughinia L, Roozmeh S, et al. , “Patients ‘ self-reported factors in fl uencing cervical cancer screening uptake among HIV-positive women in low- and middle-income countries: An integrative review,” Gynecologic Oncology Reports 33 (2020) 100596 10.1016/j.gore.2020.100596 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Javaeed A, Shoukat S, Hina S, et al. Knowledge, Attitude, and Practices Related to Cervical Cancer Among Adult Women in Azad Kashmir: A Hospital-based Cross-sectional Study. Cureus 2019; 11(3): e4234. 10.7759/cureus.4234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Alwan AS, Al-Attar WM, Al Mallah N, and Abdulla KN, “Ass sessing the Knowle edge, Attitude e and Practi ices Tow wards Cervica C al Cance er Scree ening Among a Sample of Iraqi Female Populati ion,”Iraqi i Journal of Biotechnology 2017, Vol. 16, No. 2, 38‐47 [Google Scholar]
  • 36.Moshi FV, Bago M, Ntwenya J, Mpondo B, Kibusi SM. Uptake of Cervical Cancer Screening Services and Its Association with Cervical Cancer Awareness and Knowledge Among Women of Reproductive Age in Dodoma, Tanza- nia: A Cross-Sectional Study. East Afr Health Res J. 2019;3(2):105–114. 10.24248/EAHRJ-D-19-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Amu EO, Ndugba SC, Olatona FA. Knowledge of Cervical Cancer and Attitude to Cervical Cancer Screening among Women in Somolu Local Government Area, Lagos, Nigeria; Journal of Community Medicine and Primary Health Care. 2019; 31 (1) 76–85. [Google Scholar]

Decision Letter 0

Saeed Ahmed

4 Mar 2021

PONE-D-21-03081

Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis

PLOS ONE

Dear Dr. Bogale

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 3/27/2021 If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Saeed Ahmed, MD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please confirm that you have included all items recommended in the PRISMA checklist including:

-    the full electronic search strategy used to identify studies with all search terms and limits for at least one database.

-    an explanation for why the search inclusion dates were only for the past 10 years

-    a Supplemental file of the results of the individual components of the quality assessment, not just the overall score, for each study included.

-    See https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000100#pmed-1000100-t003 for guidance on reporting.

Thank you.

3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

4.Thank you for stating the following financial disclosure:

 "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

  3. If any authors received a salary from any of your funders, please state which authors and which funders.

  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Partly

Reviewer #5: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

Reviewer #4: Yes

Reviewer #5: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

This is a systematic review and meta-analysis regarding the knowledge, attitude and practice towards cervical cancer screening in Africa. The study included eight published papers and found that the estimated pooled proportion of knowledge, attitudes and practices among the participants were 43%, 38% and 41% respectively.

Major strength of the study was the large number of participants from the pooled review and statistical analysis. Weaknesses include only eight published papers from a large time frame which is not well described.

There are quite a number of grammatical errors.

I have added some of the grammatical errors and sentence formation that needs to be revised. Some areas are not clear as to what the authors are trying to convey.

Line 31 To establish successful strategies and increasing the utilization of preventive services

Line 38 Methods- Would help to have definite time frame- says till august 2020 but does not say from when

Line 50 Conclusion: The pooled estimates of knowledge, attitude and practice were lower than other developed countries calls for further activities to enhance the uptake of the services and establish successful strategies.

Line 79 When looked at the patients suffered gynecological cancer, more than half of them knew that their disease was malignant

Line 80 In addition, different evidence about knowledge, attitude and practice were generated at different corners of Asian countries [9] [10] [11] [12] that seek for pooling of the findings for decision making.

Line 88 On the basis of the comprehensive literature search made, variability on the KAP score prevails in various African countries assumed have high prevalence of the problem and moreover unavailability of information among the female population living with HIV who are the most vulnerable population.

Line 119 In this review, we included a cross sectional studies conducted in Africa

Line 120 The inclusion was restricted to papers published in the English language within a ten year period till last August 2020

Page 6- identification tab states n=131 and gives the number of articles in each database but they do not add up to 131. They only add up to 85.

Line 168-170 We extracted data from eligible abstract and/or full text of the articles by considering the outcome variables and the characteristics of participants such as age range, mean or median age, sex, HIV sero-status.

Line 193 Almost all included studies were cross-sectional types published from 2014 to 2019 though the extraction of data was done for the past ten years till August 2020.

Reviewer #2: Study is a Systematic review and meta-analysis, with no conflict of interests from authors and no conflict from a funding perspective. Published articles were from well accepted and vetted databases in accordance with PRISMA. Authors included cross sectional studies conducted in Africa that reported Knowledge, attitude and practice towards cervical cancer screening in HIV. Study has included 131 articles based on initial screening and after applying Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies, total 8 articles were analyzed.

Study, very importantly is addressing the key aspect to devise a well though out prevention strategy: the knowledge, attitude and practice (KAP) of a particular subgroup. The study goal is especially important as the group is the female population living with HIV who are the most vulnerable population. Documentation of KAP among HIV infected African women towards cervical cancer screening will have positive effects towards the goal to decrease HIV prevalence, viral suppression HIV as well as the comorbidity of Cervical Cancer. I think it was an appropriate to restrict the studies done within the last 10 years as we are trying to assess the current KAP.

Minor revision Recommendations.

1. 8 studies evaluated where all healthcare facility based. It will be appropriate to know what kind of facility. For example, if all the patients were from a tertiary hospital vs rural health center, I will worry about disparity in healthcare access creating a bias on KAP. Can the authors clarify that with an additional chart?

2. Most patients were from Ethiopia and the difference in health system from different countries can affect the generalizability of the result to whole of the African Continent. Can that be clarified? If not mentioned as a concern in the discussion.

3. Study team could have included CD4 as well as AIDS terms to their search strategy key terms broadening some data collection keeping immune suppression in mind. Cervical cancer incidence correlate with a lower CD4 count. ( JAMA. 2005;293:1471–1476.)

Reviewer #3: Well written paper with nice introduction, aim, and clear methodology, few points that i feel should be addressed please:

- The author need to define in the methodology what they meant by knowledge, attitude and practice (KAP)

- Page 2, line 42, no need to say last August 2020, August 2020 is enough

- Page 3, line 70 add measures after preventive

- Page 5, 2nd paragraph starting with PubMed need to be revised as it include a lot of unnecessary punctuation marks

- Page 5, line 121, again no need to say last August 2020, August 2020 is enough

- Page 13, line 307, again no need to say last August 2020, August 2020 is enough

- The conclusion need to be more precise.

Reviewer #4: - the manuscript needs some minor grammatical/language corrections.

- it is hard to assess the numbers- how do you decide whether knowledge/attitude/practice is appropriate or not? what are the specific parameters you used to decide to decide whether KAP is prevalent or not.

- also as expected there is lot of heterogeneity among the studies.

- in the abstract, the authors have mentioned that KAP is less compared to developed nations, although in the discussion section most comparisons are made to low/middle income and developing nations. Can authors cite and compare their finding with some studies from North American/European/Developed nations

Reviewer #5: This manuscript pooled results about the percentage of knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa using meta-analysis. I have below comments.

The overall statistical analysis follows the routine methods of meta-analysis. There are big heterogeneities among studies. It is not necessary to calculate pooled estimates for those results. The heterogeneity may exist because different level of health care, service or education between locations. There might be other factors too. It will be informative to investigate the reason of such existing heterogeneity in knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

Reviewer #5: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Apr 8;16(4):e0249960. doi: 10.1371/journal.pone.0249960.r002

Author response to Decision Letter 0


7 Mar 2021

Manuscript PONE-D-21-03081

Response to Editor and Reviewers

Thank you for the valued comments, and the effort made to improve our manuscript titled, Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis. We are very grateful for the insightful comments and the input made. Based on the valuable suggestions forwarded, we revised the MS and incorporated all the comments as appropriate and highlighted the changes made.

Regarding the suggestion on grammatical errors, senior instructors and co-authors critically reviewed, and online Spell checker – grammar and spell check in English - Reverso was used to check the spelling and grammar of the manuscript submitted. As commented by all reviewers, the entire manuscript is reassessed and minor corrections are made accordingly in the revised version. It is a privilege to work with you in the future prospects considering quality of the review and hard work.

The followings are the line by line responses made for the valued suggestions and comments raised by your esteemed Editors and reviewers;

Editor comments:

Comment 1. Check PLOS ONE's style requirements

• Authors' response: Thank you for pointing out this issue. The revised manuscript followed PLOS ONE manuscript formatting guidelines, including use of level 1 heading for all major sections, bold type, 18pt font.

Comment 2. Confirm that you have included all items recommended in the PRISMA checklist

• Authors' response: Thank you. We confirmed that all the items in the PRISMA checklist are included and the search strategy is well described on page 5 of the manuscript.

• We tried to restrict the studies done within the last 10 years since we were interested to assess the recent/current knowledge, attitude and practice of HIV positive women towards cervical cancer screening.

• The results of the individual components of quality assessment are included as a supplemental file (S2 Table) as suggested.

Comment 3. Include a table as part of main manuscript.

• Authors' response: Thank you and we have inserted the tables as suggested in the revised version of the manuscript [page 8]

Comment 4. State the financial disclosure

• Authors' response. Comment incorporated [Page 16].

Comment 5. PLOS requires an ORCID iD for the corresponding author

• Author response. Thank you. Comment incorporated and the ORCID iD for the corresponding author's is 0000-0002-2794-8251

Comment 6. Your ethics statement should only appear in the Methods section of your manuscript

• Authors' response: Thank and the comments is incorporated. [Page 9]

Comment 7. Include captions for your Supporting Information files at the end of your manuscript

• Authors' response: Comment incorporated.

Reviewers' Comments:

Reviewers' Comments Authors response Remark

Reviewer #1 Grammatical errors Done as suggested.

Definite time frame for search

The search is already filtered by selecting 10 years in the left corner of database search till the time of data extraction which is August 2020.

The number of articles identified do not add-up to 131 Thank you for pointing this out. The records identified via Google scholar (n=46) are covered due to font size and now visible.

Reviewer #2 -I will worry about disparity in healthcare access creating a bias on KAP

- Most patients were from Ethiopia and the difference in health system from different countries can affect the generalizability of the result to whole of the African Continent

- Cervical cancer incidence correlate with a lower CD4 count Thank you very much for your valuable comments and suggestions.

-Our review was conducted among HIV population from ART clinics with more or less similar characteristics in terms of awareness and practice.

- Only two articles are included in the analysis from Ethiopia, which fulfilled the eligibility criteria. [Table 1][Page 8]

- Sure! Immunosuppression hasan association with cervical cancer, but our aim here was to pool KAP estimates on cervical cancer among HIV population.

Reviewer #3 -Define in the methodology what they meant by knowledge, attitude and practice (KAP)

Thank you for your valuable comments and suggestions.

- We included the operational definition of KAP under the methods section [Page 9].

- Other comments are also included in the revised manuscript.

-

Reviewer #4 What are the specific parameters you used to decide whether KAP is prevalent or not? Our aim in this regard is to pool the pocket studies which reported the proportions of KAP among HIV positive women. Based on this finding, our next step is to use structured questionnaire to address KAP issue in the subsequent original study and establish the average score.

Other comments also incorporated into the protocol.

Reviewer #5 It will be informative to investigate the reason of such existing heterogeneity in knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa.

Thank you very much for your valuable comment.

-We tried to use meta-regression to rule out heterogeneity on KAP considering variation in the sample size and years of publication might cause heterogeneity observed. [Page 11] and as you can see from Table 1, age, even reported in age range, mean age, etc., which is very difficult to run a meta-regression to rule-out heterogeneity due to age.

Thank you very much,

Authors'

Attachment

Submitted filename: Response to Reviewers-PONE.docx

Decision Letter 1

Saeed Ahmed

29 Mar 2021

Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis

PONE-D-21-03081R1

Dear Dr. Bogale

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Saeed Ahmed, MD

Academic Editor

PLOS ONE

Acceptance letter

Saeed Ahmed

31 Mar 2021

PONE-D-21-03081R1

Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis

Dear Dr. Bogale:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Saeed Ahmed

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. PROSPERO International prospective register of systematic reviews.

    (PDF)

    S1 Table. PRISMA assessment checklist.

    (DOC)

    S2 Table. The results of the individual components of the quality assessment.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers-PONE.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES